Geode Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Buy
976,650
+89,825
+10% +$2.2M ﹤0.01% 2017
2025
Q4
$23.8M Sell
886,825
-35,752
-4% -$921K ﹤0.01% 1907
2025
Q3
$24.6M Sell
922,577
-50,660
-5% -$1.31M ﹤0.01% 1894
2025
Q2
$22.3M Buy
973,237
+18,161
+2% +$451K ﹤0.01% 1900
2025
Q1
$27.7M Buy
955,076
+38,995
+4% +$1.25M ﹤0.01% 1722
2024
Q4
$34M Sell
916,081
-4,282
-0.5% -$196K ﹤0.01% 1667
2024
Q3
$44.7M Buy
920,363
+14,015
+2% +$615K ﹤0.01% 1492
2024
Q2
$36.3M Buy
906,348
+40,316
+5% +$1.67M ﹤0.01% 1572
2024
Q1
$38M Buy
866,032
+19,380
+2% +$1M ﹤0.01% 1535
2023
Q4
$52.4M Buy
846,652
+37,026
+5% +$1.95M 0.01% 1319
2023
Q3
$37.2M Buy
809,626
+29,367
+4% +$1.6M ﹤0.01% 1419
2023
Q2
$44.8M Buy
780,259
+20,278
+3% +$899K 0.01% 1329
2023
Q1
$28.5M Buy
759,981
+37,700
+5% +$1.24M ﹤0.01% 1569
2022
Q4
$20.2M Buy
722,281
+14,075
+2% +$409K ﹤0.01% 1765
2022
Q3
$19.9M Buy
708,206
+15,818
+2% +$516K ﹤0.01% 1743
2022
Q2
$24.1M Sell
692,388
-11,091
-2% -$396K ﹤0.01% 1637
2022
Q1
$25.3M Sell
703,479
-11,394
-2% -$323K ﹤0.01% 1727
2021
Q4
$16.6M Buy
714,873
+10,958
+2% +$224K ﹤0.01% 2083
2021
Q3
$13.4M Buy
703,915
+14,831
+2% +$290K ﹤0.01% 2253
2021
Q2
$13.9M Buy
689,084
+28,671
+4% +$540K ﹤0.01% 2231
2021
Q1
$12.1M Buy
660,413
+86,269
+15% +$1.6M ﹤0.01% 2235
2020
Q4
$11.5M Buy
574,144
+31,877
+6% +$620K ﹤0.01% 2068
2020
Q3
$10.2M Buy
542,267
+1,747
+0.3% +$35.2K ﹤0.01% 1941
2020
Q2
$12.1M Buy
540,520
+6,442
+1% +$118K ﹤0.01% 1813
2020
Q1
$7.92M Buy
534,078
+29,250
+6% +$509K ﹤0.01% 1881
2019
Q4
$9.74M Buy
504,828
+12,807
+3% +$246K ﹤0.01% 2026
2019
Q3
$9.76M Buy
492,021
+7,809
+2% +$163K ﹤0.01% 1949
2019
Q2
$10.2M Buy
484,212
+39,634
+9% +$829K ﹤0.01% 1940
2019
Q1
$9.08M Buy
444,578
+19,277
+5% +$432K ﹤0.01% 1960
2018
Q4
$8.46M Buy
425,301
+36,784
+9% +$725K ﹤0.01% 1884
2018
Q3
$7.47M Buy
388,517
+7,658
+2% +$136K ﹤0.01% 2119
2018
Q2
$5.81M Buy
380,859
+39,393
+12% +$688K ﹤0.01% 2238
2018
Q1
$6.4M Buy
341,466
+8,642
+3% +$162K ﹤0.01% 2083
2017
Q4
$6.4M Buy
332,824
+5,435
+2% +$101K ﹤0.01% 2068
2017
Q3
$5.85M Buy
327,389
+8,358
+3% +$137K ﹤0.01% 2105
2017
Q2
$5.7M Sell
319,031
-41,047
-11% -$651K ﹤0.01% 2061
2017
Q1
$5.22M Buy
360,078
+23,709
+7% +$373K ﹤0.01% 2079
2016
Q4
$6.2M Sell
336,369
-24,783
-7% -$482K ﹤0.01% 1916
2016
Q3
$6.85M Buy
361,152
+62,855
+21% +$1.14M ﹤0.01% 1747
2016
Q2
$4.81M Buy
298,297
+17,017
+6% +$240K ﹤0.01% 1941
2016
Q1
$3.38K Buy
281,280
+18,680
+7% +$220K ﹤0.01% 2119
2015
Q4
$3.74M Buy
262,600
+60,140
+30% +$794K ﹤0.01% 2079
2015
Q3
$2.37M Buy
202,460
+110,575
+120% +$1.66M ﹤0.01% 2337
2015
Q2
$1.61M Buy
91,885
+16,631
+22% +$259K ﹤0.01% 2623
2015
Q1
$1.13M Buy
75,254
+29,314
+64% +$392K ﹤0.01% 2810
2014
Q4
$533K Buy
45,940
+10,231
+29% +$111K ﹤0.01% 3162
2014
Q3
$415K Buy
+35,709
New +$372K ﹤0.01% 3247

Other funds holding AMPH